Molecular dynamics and high throughput binding free energy calculation of anti-actin anticancer drugs-New insights

Roopa L1, Pravin Kumar R2, Sudheer Mohammed M M3

  • 1Research and Development Centre, Bharathiar University, Coimbatore, India; Department of Biotechnology, Mount Carmel College, Bangalore, India.

Insights

This study compares how Latrunculin A and Reidispongiolide bind to actin, revealing key interactions for designing improved anticancer drugs that target the actin cytoskeleton.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The actin cytoskeleton is crucial for cancer progression.
  • Various anticancer toxins target actin, with distinct binding sites and mechanisms.
  • Latrunculin A (LAT) and Reidispongiolide (RGA) are examples of actin-binding anticancer agents.

Purpose of the Study:

  • To comparatively analyze the molecular dynamics of actin-drug complexes with LAT and RGA.
  • To predict potential modifications for enhancing the efficacy of these actin binders.
  • To elucidate the specific interactions governing allosteric modulation of ATP binding.

Main Methods:

  • Comparative molecular dynamics (MD) simulations of actin-drug complexes (50ns each).
  • High-throughput binding free energy calculations.
  • Per-residue energy profiling to identify key interaction sites.

Main Results:

  • Unfavorable energy sites identified for LAT (Asp157 interaction) and RGA (macrocyclic and tail regions).
  • Specific interactions mediating allosteric modulation of ATP by LAT (Glu207) and RGA were revealed.
  • RGA induces anti-correlated motions and a flattened actin structure, impacting polymerization.

Conclusions:

  • Identified specific residues and regions on actin crucial for LAT and RGA binding and allosteric modulation.
  • These findings provide a basis for rational drug design of novel actin-targeting anticancer agents.
  • Understanding these interactions is key to developing more effective therapies against cancer.

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Actin Polymerization01:42

Actin Polymerization

Actin polymerization occurs through the head-to-tail association of binding sites on monomeric actin or G-actin to form filamentous or F-actin. The polymerization can be divided into three phases ̶  nucleation, elongation, and steady-state phase.
The nucleation phase involves forming a stable nucleus consisting of three actin monomers to form a new actin filament. Actin-binding proteins such as formins and Arp2/3 complex help filament growth post-nucleation. The Formins form straight...
8.9K
Introduction to Actin01:26

Introduction to Actin

Actin is a highly conserved cytoskeletal protein found abundantly in eukaryotic cells. It constitutes 10% weight of the total cellular protein in muscle cells, while in non-muscle cells, it is lower and makes up around 1–5 percent of the total cell protein. Actin found in the unicellular amoebae and complex multicellular animals is around 80% similar, demonstrating their conservation over a billion years of evolution.  Actin coding genes are conserved within species and across...
6.9K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
4.1K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K